2GELIN J,MOLDAWER LL,LONNROCH C,et al.Role of endogenous tumor necrosis factor alpha and interleukin-1 for experimental tumor growth and the development of cancer cachexia[J].Cancer Res,1991,51:415-421.
3AZIZ N,FAHEY JL,DETELS R,et al.Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood[J].Clin Diagn Lab Immunol,2003,10:652-657.
4NOZOE T,MATSUMATA T,KITAMURA M,et al.Significance of preoperative elevation of serum C-reactive protein as an indication for prognosis in colorectal cancer[J].Am J Surg,1998,176 (4):335-338.
5YOSHIDA N,IKEMOTO S,NARITA K,et al.Interleukin-6,tumor necrosis factor alpha,and interleukin-1beta in patients with renal cell carcinoma[J].Br J Cancer,2002,86:1396-1400.
6KOJI HASHIMOTO,YASUHARU IKEDA,DAISUKE KORENAGA,et al.The impact of preperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma[J].Am Cancer Society,2005,103(9):1856-1864.
7TADAHIRO NOZOE,HIROSHI SAEKI,KEIZO SUGIMACHI.Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma[J].Am J Surg,2001,182:197-201.
8NAKANISHI H,ARAKI N,KUDAWARA I,et al.Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma[J].Int J Cancer,2002,99:167-170.
9Schneider J,Bitterlich N,Vebeits HG,et al.Fuzzy Logic -based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer[J].Int J Clin Oncol.2002; 7 (3):145-151.
10Pujol JL,Greniner J,Pcirrat E,et al Cytokeratins as serum markers in Lung Cancer:a comparison of CYFRA21-1 and TPS[J].AmJ Reapir Crit Care Med,1996,154:725-733
